vs
INNODATA INC（INOD）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
INNODATA INC的季度营收约是RIGEL PHARMACEUTICALS INC的1.0倍（$72.4M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 12.2%，领先371.8%），INNODATA INC同比增速更快（22.3% vs 21.2%），过去两年INNODATA INC的营收复合增速更高（65.3% vs 53.7%）
Innodata Inc.（曾用名Innodata Isogen）是一家美国企业，专注于提供业务流程、技术及咨询服务，同时推出相关产品，助力客户完成数字信息的创建、管理、应用与分发，支持客户提升数字化运营效率。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
INOD vs RIGL — 直观对比
营收规模更大
INOD
是对方的1.0倍
$69.8M
营收增速更快
INOD
高出1.1%
21.2%
净利率更高
RIGL
高出371.8%
12.2%
两年增速更快
INOD
近两年复合增速
53.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $72.4M | $69.8M |
| 净利润 | $8.8M | $268.1M |
| 毛利率 | 38.3% | 91.5% |
| 营业利润率 | 15.1% | 33.2% |
| 净利率 | 12.2% | 384.0% |
| 营收同比 | 22.3% | 21.2% |
| 净利润同比 | -14.2% | 1769.2% |
| 每股收益（稀释后） | $0.26 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INODRIGL
| Q4 25 | $72.4M | $69.8M | ||
| Q3 25 | $62.5M | $69.5M | ||
| Q2 25 | $58.4M | $101.7M | ||
| Q1 25 | $58.3M | $53.3M | ||
| Q4 24 | $59.2M | $57.6M | ||
| Q3 24 | $52.2M | $55.3M | ||
| Q2 24 | $32.6M | $36.8M | ||
| Q1 24 | $26.5M | $29.5M |
净利润INODRIGL
| Q4 25 | $8.8M | $268.1M | ||
| Q3 25 | $8.3M | $27.9M | ||
| Q2 25 | $7.2M | $59.6M | ||
| Q1 25 | $7.8M | $11.4M | ||
| Q4 24 | $10.3M | $14.3M | ||
| Q3 24 | $17.4M | $12.4M | ||
| Q2 24 | $-14.0K | $-1.0M | ||
| Q1 24 | $989.0K | $-8.2M |
毛利率INODRIGL
| Q4 25 | 38.3% | 91.5% | ||
| Q3 25 | 40.8% | 93.2% | ||
| Q2 25 | 39.4% | 95.6% | ||
| Q1 25 | 39.9% | 91.7% | ||
| Q4 24 | 45.2% | 89.9% | ||
| Q3 24 | 40.8% | 85.5% | ||
| Q2 24 | 28.7% | 92.4% | ||
| Q1 24 | 36.4% | 93.1% |
营业利润率INODRIGL
| Q4 25 | 15.1% | 33.2% | ||
| Q3 25 | 18.8% | 40.9% | ||
| Q2 25 | 15.3% | 60.1% | ||
| Q1 25 | 14.2% | 23.9% | ||
| Q4 24 | 19.0% | 28.9% | ||
| Q3 24 | 21.9% | 25.4% | ||
| Q2 24 | 1.0% | 1.2% | ||
| Q1 24 | 5.0% | -23.6% |
净利率INODRIGL
| Q4 25 | 12.2% | 384.0% | ||
| Q3 25 | 13.3% | 40.2% | ||
| Q2 25 | 12.4% | 58.6% | ||
| Q1 25 | 13.3% | 21.5% | ||
| Q4 24 | 17.4% | 24.9% | ||
| Q3 24 | 33.3% | 22.5% | ||
| Q2 24 | -0.0% | -2.8% | ||
| Q1 24 | 3.7% | -27.9% |
每股收益（稀释后）INODRIGL
| Q4 25 | $0.26 | $14.11 | ||
| Q3 25 | $0.24 | $1.46 | ||
| Q2 25 | $0.20 | $3.28 | ||
| Q1 25 | $0.22 | $0.63 | ||
| Q4 24 | $0.35 | $0.82 | ||
| Q3 24 | $0.51 | $0.70 | ||
| Q2 24 | $0.00 | $-0.06 | ||
| Q1 24 | $0.03 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.2M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $107.1M | $391.5M |
| 总资产 | $168.6M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资INODRIGL
| Q4 25 | $82.2M | $155.0M | ||
| Q3 25 | $73.9M | $137.1M | ||
| Q2 25 | $59.8M | $108.4M | ||
| Q1 25 | $56.6M | $77.1M | ||
| Q4 24 | $46.9M | $77.3M | ||
| Q3 24 | $26.4M | $61.1M | ||
| Q2 24 | $16.5M | $49.1M | ||
| Q1 24 | $19.0M | $49.5M |
总债务INODRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益INODRIGL
| Q4 25 | $107.1M | $391.5M | ||
| Q3 25 | $97.3M | $117.6M | ||
| Q2 25 | $86.7M | $81.9M | ||
| Q1 25 | $75.5M | $18.6M | ||
| Q4 24 | $63.5M | $3.3M | ||
| Q3 24 | $47.7M | $-14.6M | ||
| Q2 24 | $29.0M | $-29.9M | ||
| Q1 24 | $27.6M | $-31.7M |
总资产INODRIGL
| Q4 25 | $168.6M | $513.6M | ||
| Q3 25 | $152.9M | $242.5M | ||
| Q2 25 | $132.6M | $206.7M | ||
| Q1 25 | $125.2M | $176.0M | ||
| Q4 24 | $113.4M | $164.0M | ||
| Q3 24 | $88.2M | $139.4M | ||
| Q2 24 | $66.0M | $128.4M | ||
| Q1 24 | $63.6M | $126.5M |
负债/权益比INODRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $10.1M | — |
| 自由现金流率自由现金流/营收 | 13.9% | — |
| 资本支出强度资本支出/营收 | 3.9% | — |
| 现金转化率经营现金流/净利润 | 1.46× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $35.6M | — |
8季度趋势，按日历期对齐
经营现金流INODRIGL
| Q4 25 | $12.9M | $22.0M | ||
| Q3 25 | $18.8M | $24.0M | ||
| Q2 25 | $4.2M | $30.5M | ||
| Q1 25 | $10.9M | $-893.0K | ||
| Q4 24 | $17.2M | $14.5M | ||
| Q3 24 | $11.4M | $21.7M | ||
| Q2 24 | $-454.0K | $302.0K | ||
| Q1 24 | $6.8M | $-5.0M |
自由现金流INODRIGL
| Q4 25 | $10.1M | — | ||
| Q3 25 | $14.5M | — | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $15.0M | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $-3.2M | — | ||
| Q1 24 | $5.4M | — |
自由现金流率INODRIGL
| Q4 25 | 13.9% | — | ||
| Q3 25 | 23.2% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 14.6% | — | ||
| Q4 24 | 25.3% | — | ||
| Q3 24 | 19.0% | — | ||
| Q2 24 | -9.8% | — | ||
| Q1 24 | 20.5% | — |
资本支出强度INODRIGL
| Q4 25 | 3.9% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 8.4% | — | ||
| Q1 24 | 5.1% | — |
现金转化率INODRIGL
| Q4 25 | 1.46× | 0.08× | ||
| Q3 25 | 2.25× | 0.86× | ||
| Q2 25 | 0.59× | 0.51× | ||
| Q1 25 | 1.40× | -0.08× | ||
| Q4 24 | 1.67× | 1.01× | ||
| Q3 24 | 0.65× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 6.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
